Skip to main content
NanoGroup S.A. logo

NanoGroup S.A. — Investor Relations & Filings

Ticker · NNG ISIN · PLNNGRP00011 LEI · 259400HXWEAZUWRLY648 WAR Professional, scientific and technical activities
Open in API
Filings indexed 990 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country PL Poland
Listing WAR NNG

About NanoGroup S.A.

https://en.nanogroup.eu/

NanoGroup S.A. is a biotechnology company specializing in the application of nanotechnology to medicine. The company focuses on developing and licensing early-stage, pre-clinical, and Investigational New Drug (IND) solutions. Its research and development activities are concentrated on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key areas of interest include innovative anticancer therapies utilizing RNA, regenerative medicine, early diagnostics, and the development of advanced organ perfusion systems for transplantation.

Recent filings

Filing Released Lang Actions
Dopuszczenie akcji N
Regulatory Filings
2026-06-02 Polish
Publikacja dokumentu związanego z dopuszczeniem do obrotu na rynku regulowanym prowadzonym przez GPW S.A. akcji serii N - Content (PL)
Regulatory Filings
2026-06-02 Polish
Wybór formulacji płynu NanOX 4 Kidney do dalszych badań - Content (PL)
Regulatory Filings Classification · 75% confidence The document is a current (bieżący) announcement by the management of NanoGroup S.A. providing an update on R&D progress in its subsidiary NanoSanguis regarding the selection of a perfusion fluid formulation. It contains substantive scientific and project development details but no financial statements, earnings highlights, or governance changes. It is not a full annual or interim report, not an earnings release, not a capital or share issue announcement, nor a formal proxy or legal filing. This type of announcement is a regulatory news update about operational progress that does not fit the more specific categories, so it is classified under Regulatory Filings (RNS).
2026-06-01 Polish
Formularz głosu przez pełnomocnika
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy voting form for the Annual General Meeting of NanoGroup S.A. It provides shareholders with voting instructions to be given to a proxy, which is part of the proxy solicitation process rather than actual meeting minutes or results. Thus, it fits the definition of Proxy Solicitation & Information Statement (PSI).
2026-05-25 Polish
Pełnomocnictwo os. prawna
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Polish “pełnomocnictwo” (power of attorney/proxy form) allowing a shareholder to appoint a proxy to vote at the upcoming Annual General Meeting on June 25, 2026. It is a proxy card sent to shareholders requesting and facilitating the casting of votes. This falls under the Proxy Solicitation & Information Statement category (PSI).
2026-05-25 Polish
Pełnomocnictwo os. fizyczna
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a power of attorney (proxy) form allowing a shareholder to appoint a representative to attend and vote at the company’s Annual General Meeting. This form is part of proxy solicitation materials sent to shareholders to request voting instructions for a general meeting. Therefore, it falls under Proxy Solicitation & Information Statement (PSI).
2026-05-25 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.